The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line

被引:48
作者
Asher, Viren [1 ]
Warren, Averil [1 ]
Shaw, Robert [1 ]
Sowter, Heidi [3 ]
Bali, Anish [2 ]
Khan, Raheela [1 ]
机构
[1] Royal Derby Hosp, Sch Grad Entry Med & Hlth, Derby DE22 3DT, England
[2] Royal Derby Hosp, Dept Gynaecol Oncol, Derby DE22 3NE, England
[3] Univ Derby, Derby DE22 1GB, England
关键词
K+ CHANNELS; POTASSIUM CHANNELS; INHIBITION; IMIPRAMINE; EXPRESSION; CASPASE-3; CLOFILIUM; BLOCKER; HEAG1;
D O I
10.1186/1475-2867-11-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The voltage gated potassium (K+) channels Eag and HERG have been implicated in the pathogenesis of various cancers, through association with cell cycle changes and programmed cell death. The role of these channels in the onset and progression of ovarian cancer is unknown. An understanding of mechanism by which Eag and HERG channels affect cell proliferation in ovarian cancer cells is required and therefore we investigated their role in cell proliferation and their effect on the cell cycle and apoptosis of ovarian cancer cells. Methods: The presence of Eag and HERG was determined in SK-OV-3 cells using immunofluorescence and western blotting. The effect of the Eag blockers (imipramine and clofilium) and HERG blockers (E-4031 and ergtoxin) on cell proliferation was assessed using the MTS assay with further investigation of their role in the cell cycle and apoptosis determined by flow cytometry. Results: Eag and HERG channels were present in the cytoplasm and nuclei of SK-OV-3 cells. There was significant inhibition of proliferation of SK-OV-3 cells by imipramine (P < 0.001) and ergtoxin (P < 0.05) at 72 hours of culture. Incubation of cells with ergtoxin led to the accumulation of cells in the S and G2/M phase, while cells accumulated in S phase after incubation with E-4031, with no effect on apoptosis. Imipramine did not affect the cell cycle but increased the proportion of SK-OV-3 cells undergoing early apoptosis. Conclusion: Both Eag and HERG channels are expressed in SK-OV-3 ovarian cancer cells and have a role in cell proliferation. HERG channels affect the cell cycle while Eag channels are implicated in the inhibition of apoptosis of ovarian cancer cells. The family of Eag channels may represent a new therapeutic target for the treatment of ovarian cancer.
引用
收藏
页数:7
相关论文
共 23 条
[1]  
[Anonymous], CANC RES UK OV CANC
[2]   Ether a go-go potassium channels and cancer [J].
Camacho, J .
CANCER LETTERS, 2006, 233 (01) :1-9
[3]   Clofilium, a potassium channel blocker, induces apoptosis of human promyelocytic leukemia (HL-60) cells via Bcl-2-insensitive activation of caspase-3 [J].
Choi, BY ;
Kim, HY ;
Lee, KH ;
Cho, YH ;
Kong, G .
CANCER LETTERS, 1999, 147 (1-2) :85-93
[4]   Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells [J].
Crociani, O ;
Guasti, L ;
Balzi, M ;
Becchetti, A ;
Wanke, E ;
Olivotto, M ;
Wymore, RS ;
Arcangeli, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) :2947-2955
[5]   A MOLECULAR-BASIS FOR CARDIAC-ARRHYTHMIA - HERG MUTATIONS CAUSE LONG QT SYNDROME [J].
CURRAN, ME ;
SPLAWSKI, I ;
TIMOTHY, KW ;
VINCENT, GM ;
GREEN, ED ;
KEATING, MT .
CELL, 1995, 80 (05) :795-803
[6]  
DOLDERER JH, EUR J SURG ONCOL, V36, P72
[7]   The eag family of K+ channels in Drosophila and mammals [J].
Ganetzky, B ;
Robertson, GA ;
Wilson, GF ;
Trudeau, MC ;
Titus, SA .
MOLECULAR AND FUNCTIONAL DIVERSITY OF ION CHANNELS AND RECEPTORS, 1999, 868 :356-369
[8]   Mechanism of block of hEag1 K+ channels by imipramine and astemizole [J].
García-Ferreiro, RE ;
Kerschensteiner, D ;
Major, F ;
Monje, F ;
Stühmer, W ;
Pardo, LA .
JOURNAL OF GENERAL PHYSIOLOGY, 2004, 124 (04) :301-317
[9]   Effects of imipramine on ion channels and proliferation of IGR1 melanoma cells [J].
Gavrilova-Ruch, O ;
Schönherr, K ;
Gessner, G ;
Schönherr, R ;
Klapperstück, T ;
Wohlrab, W ;
Heinemann, SH .
JOURNAL OF MEMBRANE BIOLOGY, 2002, 188 (02) :137-149
[10]   Inhibition of hEAG1 and hERG1 potassium channels by clofilium and its tertiary analogue LY97241 [J].
Gessner, G ;
Heinemann, SH .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (01) :161-171